ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Approves DNA Test For Two Types of HPV

March 27, 2009

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

November 9, 1990

DeVita Says Payline Compression Leading to More Decisions By Staff On Funding

June 28, 1985

Evidence Supports Screening Younger Women, Expert Says

September 24, 1993

FDA’s Jane Henney

February 11, 1994

In Brief: Pursell Most Likely To Replace Conte, Foriend Of Cancer Program; DeVita Names Associate

February 15, 1991